Misplaced Pages

Risk–benefit ratio

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Risk-benefit analysis) Analysis of the risks and potential benefits of an action
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Risk–benefit ratio" – news · newspapers · books · scholar · JSTOR (May 2012) (Learn how and when to remove this message)

A risk–benefit ratio (or benefit-risk ratio) is the ratio of the risk of an action to its potential benefits. Risk–benefit analysis (or benefit-risk analysis) is analysis that seeks to quantify the risk and benefits and hence their ratio.

Analyzing a risk can be heavily dependent on the human factor. A certain level of risk in our lives is accepted as necessary to achieve certain benefits. For example, driving an automobile is a risk many people take daily, also since it is mitigated by the controlling factor of their perception of their individual ability to manage the risk-creating situation. When individuals are exposed to involuntary risk (a risk over which they have no control), they make risk aversion their primary goal. Under these circumstances, individuals require the probability of risk to be as much as one thousand times smaller than for the same situation under their perceived control (a notable example being the common bias in the perception of risk in flying vs. driving).

Evaluations

Evaluations of future risk can be:

  • Real future risk, as disclosed by the fully matured future circumstances when they develop.
  • Statistical risk, as determined by currently available data, as measured actuarially for insurance premiums.
  • Projected risk, as analytically based on system models structured from historical studies.
  • Perceived risk, as intuitively seen by individuals.

Medical research

For research that involves more than minimal risk of harm to the subjects, the investigator must assure that the amount of benefit clearly outweighs the amount of risk. Only if there is a favorable risk–benefit ratio may a study be considered ethical.

The Declaration of Helsinki, adopted by the World Medical Association, states that biomedical research cannot be done legitimately unless the importance of the objective is in proportion to the risk to the subject. The Helsinki Declaration and the CONSORT Statement stress a favorable risk–benefit ratio.

See also

References

  1. "Risk-Benefit Analysis". Capita.wustl.edu. Archived from the original on 2013-10-29. Retrieved 2013-10-25.
  2. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
  3. "Consort". Consort-statement.org. Retrieved 2013-10-25.
Clinical research and experimental design
Overview
Controlled study
(EBM I to II-1)
Observational study
(EBM II-2 to II-3)
Measures
OccurrenceIncidence, Cumulative incidence, Prevalence, Point prevalence, Period prevalence
AssociationRisk difference, Number needed to treat, Number needed to harm, Risk ratio, Relative risk reduction, Odds ratio, Hazard ratio
Population impactAttributable fraction among the exposed, Attributable fraction for the population, Preventable fraction among the unexposed, Preventable fraction for the population
OtherClinical endpoint, Virulence, Infectivity, Mortality rate, Morbidity, Case fatality rate, Specificity and sensitivity, Likelihood-ratios, Pre- and post-test probability
Trial/test types
Analysis of clinical trials
Interpretation of results
Categories: